Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
In conclusion, allo-HCT procedures for patients with aggressive ATL have considerably progressed and have helped improve the prognosis of these patients; however, many concerns still remain to be resolved. Further development of allo-HCT by using new molecular targeting agents is required for the improvement of cure rates in patients with ATL.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
More News: Acute Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Corticosteroid Therapy | Japan Health | Leukemia | Lymphoma | Microbiology | Revlimid | Stem Cell Therapy | Stem Cells | Study | Transplants